109 related articles for article (PubMed ID: 36821978)
1. Ceramide is implicated in humoral peripheral and intrathecal autoimmune response in MS patients.
Podbielska M; Macala J; Jakubiak-Augustyn A; Szulc ZM; Fortuna W; Budrewicz S; Jaskiewicz E; Bilinska M; Hogan EL; Pokryszko-Dragan A
Mult Scler Relat Disord; 2023 Mar; 71():104565. PubMed ID: 36821978
[TBL] [Abstract][Full Text] [Related]
2. The relevance of ceramides and their synthesizing enzymes for multiple sclerosis.
Kurz J; Brunkhorst R; Foerch C; Blum L; Henke M; Gabriel L; Ulshöfer T; Ferreirós N; Parnham MJ; Geisslinger G; Schiffmann S
Clin Sci (Lond); 2018 Sep; 132(17):1963-1976. PubMed ID: 30219773
[TBL] [Abstract][Full Text] [Related]
3. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
4. Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis.
Leurs CE; Lopes Pinheiro MA; Wierts L; den Hoedt S; Mulder MT; Eijlers AJC; Schoonheim MM; Balk LJ; Uitdehaag BMJ; Killestein J; de Vries HE
Mult Scler Relat Disord; 2019 Feb; 28():44-49. PubMed ID: 30553168
[TBL] [Abstract][Full Text] [Related]
5. Analysis of CSF D-Dimer to Identify Intrathecal Fibrin-Driven Autoimmunity in Patients With Multiple Sclerosis.
Schaller-Paule MA; Yalachkov Y; Steinmetz H; Friedauer L; Hattingen E; Miesbach W; Weber F; Kirchmayr K; Schaefer JH; Foerch C
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260469
[TBL] [Abstract][Full Text] [Related]
6. Plasma C18:0-ceramide is a novel potential biomarker for disease severity in myasthenia gravis.
Zhang Z; Huang X; Du X; Wang Z; Wang Y; Xu M; Chen X; Yao Q; Yan L; Zhang Y
J Neurochem; 2023 Jun; 165(6):907-919. PubMed ID: 37158660
[TBL] [Abstract][Full Text] [Related]
7. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
[TBL] [Abstract][Full Text] [Related]
9. CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.
Tamam Y; Gunes B; Akbayir E; Kizilay T; Karaaslan Z; Koral G; Duzel B; Kucukali CI; Gunduz T; Kurtuncu M; Yilmaz V; Tuzun E; Turkoglu R
Mult Scler Relat Disord; 2021 Feb; 48():102697. PubMed ID: 33352356
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Doronin VB; Parkhomenko TA; Castellazzi M; Cesnik E; Buneva VN; Granieri E; Nevinsky GA
PLoS One; 2016; 11(5):e0154688. PubMed ID: 27196086
[TBL] [Abstract][Full Text] [Related]
11. Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke.
Fiedorowicz A; Kozak-Sykała A; Bobak Ł; Kałas W; Strządała L
Neurol Neurochir Pol; 2019; 53(6):484-491. PubMed ID: 31804702
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.
Doronin VB; Parkhomenko TA; Castellazzi M; Padroni M; Pastore M; Buneva VN; Granieri E; Nevinsky GA
PLoS One; 2014; 9(9):e107807. PubMed ID: 25265393
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Evangelopoulos ME; Koutsis G; Boufidou F; Markianos M
Neurobiol Dis; 2022 Nov; 174():105889. PubMed ID: 36209949
[TBL] [Abstract][Full Text] [Related]
14. Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.
Parkhomenko TA; Doronin VB; Castellazzi M; Padroni M; Pastore M; Buneva VN; Granieri E; Nevinsky GA
PLoS One; 2014; 9(4):e93001. PubMed ID: 24736683
[TBL] [Abstract][Full Text] [Related]
15. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
[TBL] [Abstract][Full Text] [Related]
16. Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes.
Juchnicka I; Kuźmicki M; Zabielski P; Krętowski A; Błachnio-Zabielska A; Szamatowicz J
J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054078
[TBL] [Abstract][Full Text] [Related]
17. Extreme Diversity of IgGs Against Histones, DNA, and Myelin Basic Protein in the Cerebrospinal Fluid and Blood of Patients with Multiple Sclerosis.
Kostrikina IA; Buneva VN; Granieri E; Nevinsky GA
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32325782
[TBL] [Abstract][Full Text] [Related]
18. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
19. Nano-LC-MS/MS for the quantitation of ceramides in mice cerebrospinal fluid using minimal sample volume.
Thomas D; Eberle M; Schiffmann S; Zhang DD; Geisslinger G; Ferreirós N
Talanta; 2013 Nov; 116():912-8. PubMed ID: 24148494
[TBL] [Abstract][Full Text] [Related]
20. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
Ge K; Zheng D; Wang J; Jia W; Zhao A
Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
